178 related articles for article (PubMed ID: 17335772)
1. Double mutant P96S/S120G of Nm23-H1 abrogates its NDPK activity and motility-suppressive ability.
Zhou Q; Yang X; Zhu D; Ma L; Zhu W; Sun Z; Yang Q
Biochem Biophys Res Commun; 2007 May; 356(2):348-53. PubMed ID: 17335772
[TBL] [Abstract][Full Text] [Related]
2. Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2.
Horak CE; Lee JH; Elkahloun AG; Boissan M; Dumont S; Maga TK; Arnaud-Dabernat S; Palmieri D; Stetler-Stevenson WG; Lacombe ML; Meltzer PS; Steeg PS
Cancer Res; 2007 Aug; 67(15):7238-46. PubMed ID: 17671192
[TBL] [Abstract][Full Text] [Related]
3. Nucleoside diphosphate kinase A/nm23-H1 promotes metastasis of NB69-derived human neuroblastoma.
Almgren MA; Henriksson KC; Fujimoto J; Chang CL
Mol Cancer Res; 2004 Jul; 2(7):387-94. PubMed ID: 15280446
[TBL] [Abstract][Full Text] [Related]
4. Site-directed mutation of Nm23-H1. Mutations lacking motility suppressive capacity upon transfection are deficient in histidine-dependent protein phosphotransferase pathways in vitro.
Freije JM; Blay P; MacDonald NJ; Manrow RE; Steeg PS
J Biol Chem; 1997 Feb; 272(9):5525-32. PubMed ID: 9038158
[TBL] [Abstract][Full Text] [Related]
5. [The Study on the Phosphorylation Activity of Mutant nm23-H1.].
Yang X; Ma L; Zhu D; Wang D; Wang G; Zhou Q
Zhongguo Fei Ai Za Zhi; 2009 Mar; 12(3):193-7. PubMed ID: 20716420
[TBL] [Abstract][Full Text] [Related]
6. [Effects of nm23-H1 point mutation on activity of GSK-3β in human high-metastatic large cell lung cancer cell line L9981].
Ma L; Zhou Q; Zhu W; Zhu D; Yang X; Wang Y; Chen X; Zhang M; Gao L; Zhap Y
Zhongguo Fei Ai Za Zhi; 2006 Feb; 9(1):30-4. PubMed ID: 21144278
[TBL] [Abstract][Full Text] [Related]
7. Point mutations affecting the oligomeric structure of Nm23-H1 abrogates its inhibitory activity on colonization and invasion of prostate cancer cells.
Kim YI; Park S; Jeoung DI; Lee H
Biochem Biophys Res Commun; 2003 Jul; 307(2):281-9. PubMed ID: 12859952
[TBL] [Abstract][Full Text] [Related]
8. A nucleoside diphosphate kinase A (nm23-H1) serine 120-->glycine substitution in advanced stage neuroblastoma affects enzyme stability and alters protein-protein interaction.
Chang CL; Strahler JR; Thoraval DH; Qian MG; Hinderer R; Hanash SM
Oncogene; 1996 Feb; 12(3):659-67. PubMed ID: 8637723
[TBL] [Abstract][Full Text] [Related]
9. Protein phosphorylation corrects the folding defect of the neuroblastoma (S120G) mutant of human nucleoside diphosphate kinase A/Nm23-H1.
Mocan I; Georgescauld F; Gonin P; Thoraval D; Cervoni L; Giartosio A; Dabernat-Arnaud S; Crouzet M; Lacombe ML; Lascu I
Biochem J; 2007 Apr; 403(1):149-56. PubMed ID: 17155928
[TBL] [Abstract][Full Text] [Related]
10. Two-component kinase-like activity of nm23 correlates with its motility-suppressing activity.
Wagner PD; Steeg PS; Vu ND
Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9000-5. PubMed ID: 9256424
[TBL] [Abstract][Full Text] [Related]
11. [Construction of human nm23-H1 mutant and EGFP fusion genes using site-directed mutagenesis].
Zhu D; Zhou Q; Wang Y; Zhu W; Chen X; Sun Z
Zhongguo Fei Ai Za Zhi; 2006 Apr; 9(2):117-22. PubMed ID: 21144294
[TBL] [Abstract][Full Text] [Related]
12. Nm23-H1: a metastasis-associated gene.
Tee YT; Chen GD; Lin LY; Ko JL; Wang PH
Taiwan J Obstet Gynecol; 2006 Jun; 45(2):107-13. PubMed ID: 17197349
[TBL] [Abstract][Full Text] [Related]
13. Site-directed mutagenesis of nm23-H1. Mutation of proline 96 or serine 120 abrogates its motility inhibitory activity upon transfection into human breast carcinoma cells.
MacDonald NJ; Freije JM; Stracke ML; Manrow RE; Steeg PS
J Biol Chem; 1996 Oct; 271(41):25107-16. PubMed ID: 8810265
[TBL] [Abstract][Full Text] [Related]
14. Identification of structural domains affecting transactivation potential of Nm23.
Cho SJ; Lee NS; Jung YS; Lee H; Lee KJ; Kim E; Chae SK
Biochem Biophys Res Commun; 2001 Dec; 289(3):738-43. PubMed ID: 11726210
[TBL] [Abstract][Full Text] [Related]
15. P53 is a regulator of the metastasis suppressor gene Nm23-H1.
Chen SL; Wu YS; Shieh HY; Yen CC; Shen JJ; Lin KH
Mol Carcinog; 2003 Apr; 36(4):204-14. PubMed ID: 12669312
[TBL] [Abstract][Full Text] [Related]
16. Neuroblastoma specific effects of DR-nm23 and its mutant forms on differentiation and apoptosis.
Negroni A; Venturelli D; Tanno B; Amendola R; Ransac S; Cesi V; Calabretta B; RaschellĂ G
Cell Death Differ; 2000 Sep; 7(9):843-50. PubMed ID: 11042679
[TBL] [Abstract][Full Text] [Related]
17. Metastasis suppressor function of NM23-H1 requires its 3'-5' exonuclease activity.
Zhang Q; McCorkle JR; Novak M; Yang M; Kaetzel DM
Int J Cancer; 2011 Jan; 128(1):40-50. PubMed ID: 20209495
[TBL] [Abstract][Full Text] [Related]
18. The nucleoside diphosphate kinase activity of DRnm23 is not required for inhibition of differentiation and induction of apoptosis in 32Dcl3 myeloid precursor cells.
Venturelli D; Cesi V; Ransac S; Engelhard A; Perrotti D; Calabretta B
Exp Cell Res; 2000 Jun; 257(2):265-71. PubMed ID: 10837140
[TBL] [Abstract][Full Text] [Related]
19. Expression of a catalytically inactive H118Y mutant of nm23-H2 suppresses the metastatic potential of line IV Cl 1 human melanoma cells.
Hamby CV; Abbi R; Prasad N; Stauffer C; Thomson J; Mendola CE; Sidorov V; Backer JM
Int J Cancer; 2000 Nov; 88(4):547-53. PubMed ID: 11058869
[TBL] [Abstract][Full Text] [Related]
20. [The mechanism of metastasis suppressor gene nm23-H1 involving in the Ras signaling of lung cancer.].
Yang X; Yao Y; Zhu W; Ma L; Zhu D; Xiao W; Li C; Ma J; Zhang Z; Gao L; Wang Y; Zhou Q
Zhongguo Fei Ai Za Zhi; 2008 Oct; 11(5):700-3. PubMed ID: 20738916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
